Alliancebernstein L.P. Syros Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $36,432 - $63,888	-52,800 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.02 - $3.8 $204 - $760	200 Added 0.38%	52,800 $63,000
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $10,758 - $15,378	-3,300 Reduced 5.9%	52,600 $171,000
Q2 2021 Jul 30, 2021	BUY	$5.01 - $7.48 $99,198 - $148,104	19,800 Added 54.85%	55,900 $305,000
Q1 2021 May 06, 2021	SELL	$7.19 - $14.95 $57,520 - $119,600	-8,000 Reduced 18.14%	36,100 $270,000
Q4 2020 Feb 08, 2021	SELL	$6.66 - $14.66 $33,966 - $74,766	-5,100 Reduced 10.37%	44,100 $478,000
Q2 2020 Aug 13, 2020	BUY	$5.21 - $11.03 $50,016 - $105,888	9,600 Added 24.24%	49,200 $524,000
Q1 2020 May 14, 2020	BUY	$4.46 - $9.2 $40,586 - $83,720	9,100 Added 29.84%	39,600 $235,000
Q4 2019 Feb 18, 2020	BUY	$4.52 - $10.1 $6,327 - $14,140	1,400 Added 4.81%	30,500 $211,000
Q3 2019 Nov 14, 2019	BUY	$7.14 - $11.65 $59,976 - $97,860	8,400 Added 40.58%	29,100 $302,000
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $25,850 - $45,825	4,700 Added 29.38%	20,700 $192,000
Q1 2019 May 14, 2019	BUY	$5.51 - $9.59 $19,285 - $33,565	3,500 Added 28.0%	16,000 $146,000
Q3 2018 Nov 08, 2018	BUY	$9.74 - $12.92 $8,766 - $11,628	900 Added 7.76%	12,500 $149,000
Q2 2018 Aug 13, 2018	BUY	$10.16 - $13.65 $117,856 - $158,340	11,600 New	11,600 $118,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.